Encinitas, CA, January 13, 2011 --(PR.com)-- acroMIS announced it has added a white paper titled: “Launching Your Medical Device Products In Other Countries” to the resources available from acroMIS for VC firms, entrepreneurs, start-up, and early-stage device companies. In a detailed process description, acroMIS International Medical Consulting explains how U.S. medical device startups can benefit from early clinical uses in Europe. The first part of the paper is titled, “New European Markets Can Bring Tangible Value to U.S. Device Companies,” and describes the strategy for the implementation of early clinical uses in Europe. The second part is titled, “Free Movement Of U.S. Devices Within The European Market,” and focuses on how to implement European CE marking requirements. The third part is titled, “European In-country Opportunity Assessment: Commercial Implementation and Business Development of U.S. Medical Innovation,” and focuses on the pathway to early clinical uses and commercial success in Europe.
